FDA

FDA turns ‘blind eye’ to safety violations as Indian drugmaker ships generics to US

The following information is from Children’s Health Defense. A major investigation has found that the Food and Drug Administration (FDA) repeatedly overlooked serious safety violations at Sun Pharma’s factory in Halol, India, one of the world’s largest suppliers of generic drugs

FDA turns ‘blind eye’ to safety violations as Indian drugmaker ships generics to US Read More »

Scroll to Top